findmyKOL
Clinical trialNCT05077254CompletedPhase 2Interventional

COVID Protection After Transplant-Immunosuppression Reduction

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment48Kidney Transplant RecipientsLiver Transplant Recipients
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Christian P. Larsen, MD, DPhil

    Emory Transplant Center, Emory University School of Medicine

    Study Chair
  • Dorry L. Segev, MD, PhD

    Transplant Surgery, Johns Hopkins University School of Medicine

    Study Chair
  • Peter S. Heeger, MD

    Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California, San Diego

    San Diego, California, United States

  • University of California San Francisco Health

    San Francisco, California, United States

  • Emory Healthcare

    Atlanta, Georgia, United States

  • University of Illinois Health

    Chicago, Illinois, United States

  • Northwestern University

    Evanston, Illinois, United States

  • University of Iowa Hospitals

    Iowa City, Iowa, United States

  • Ochsner Health

    New Orleans, Louisiana, United States

  • Johns Hopkins Institute for Clinical and Translational Research: Broadway Adult Outpatient Clinical Research Unit

    Baltimore, Maryland, United States

  • Mt. Sinai Hospital

    New York, New York, United States

  • Nyu Langone Transplant Institute

    New York, New York, United States

  • Weill Cornell Medicine

    New York, New York, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • Houston Methodist

    Houston, Texas, United States

  • University of Wisconsin-Madison

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
6 Dec 2021
Primary completion
28 Feb 2024
Completion
21 Feb 2025
Last update posted
23 Apr 2026
Registered enrollment
48
Registry id
NCT05077254

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.